Beyond the guidelines: Fatal and near-fatal asthma

Paediatric Respiratory Reviews

Volumn 13, Issue 2, 2012, Pages 106-111

  Rubin, Bruce K ^a   Pohanka, Vladimir ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Martin University   (Slovakia)

Author keywords

Asthma; Beta agonists; Corticosteroids; Mechanical ventilation; Neutrophils

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; HELIOX; LEVALBUTEROL; MAGNESIUM; METHYLPREDNISOLONE; MONTELUKAST; OXYGEN; PLACEBO; PREDNISONE; SALBUTAMOL;

AEROSOL; ARTIFICIAL VENTILATION; ASTHMA; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FATALITY; GENETIC RISK; HEART ARRHYTHMIA; HUMAN; HYPERCAPNIA; HYPOGLYCEMIA; HYPOKALEMIA; MORBIDITY; MORTALITY; MUCUS SECRETION; OXYGEN THERAPY; PATIENT EDUCATION; PHENOTYPE; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; TREMOR;

ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; HUMANS; OXYGEN INHALATION THERAPY; RESPIRATION, ARTIFICIAL; RISK FACTORS;

EID: 84859265231     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2011.05.003     Document Type: Review

References (64)

1. Bloom B, Cohen RA. Summary health statistics for U.S. children: National Health Interview Survey, 2006. Vital Health Stat 10. 2007;234:1-79.
2. Moorman J.E., Rudd R.A., Johnson C.A., King M., Minor P., Bailey C., Scalia M.R., Akinbami L.J. National surveillance for asthma--United States, 1980-2004. MMWR Surveill Summary 2007, 56:1-54.
3. Suissa S., Ernst P., Benayoun S., Baltzan M., Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000, 343:332-336.
4. Alvarez G.G., Schulzer M., Jung D., Fitzgerald J.M. A systematic review of risk factors associated with near-fatal and fatal asthma. Can Respir J 2005, 12:265-270.
5. Moore W.C., Peters SP Severe asthma: an overview. J Allergy Clin Immunol 2006, 117:487-494.
6. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007;5 Suppl:S94-138.
7. Carroll C.L., Uygungil B., Zucker A.R., Schramm C.M. Identifying an at-risk population of children with recurrent near-fatal asthma exacerbations. J Asthma 2010, 47:460-464.
8. Mitchell I., Tough S.C., Semple L.K., et al. Near fatal asthma a population-based study of risk factors. Chest 2002, 121:1407-1413.
9. Schmitz T., von Kries R., Wjst M., et al. A nationwide survey in Germany on fatal and near-fatal asthma in children: Different criteria. Eur Repir J 2000, 16:845-849.
10. Lyell P.J., Villanueva E., Burton D., et al. Risk factors for intensive care in children with acute asthma. Respirology 2005, 10:436-441.
11. Moore R.B., Wagner R., Weiss K.B. A community-based study of near fatal asthma. Ann Allergy Asthma Immunol 2001, 86:190-195.
12. O'Byrne P.M., Pedersen S., Lamm C.J., Tan W.C., Busse W.W. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 2009, 179:19-24. START Investigators Group.
13. Milgrom H., Bender B., Ackerson L., Bowry P., Smith B., Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996, 98:1051-1057.
14. Cluley S., Cochrane G.M. Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steroids. Resp Med 2001, 95:37-39.
15. Kaptein A.A., Hughes B.M., Scharloo M., Fischer M.J., Snoei L., Weinman J., Rabe K.F. Illness perceptions about asthma are determinants of outcome. Asthma 2008, 45:459-464.
16. Bender B., Milgrom H., Rand C., Ackerson L. Psychological factors associated with medication nonadherence in asthmatic children. J Asthma 1998, 35:347-353.
17. Julius S.M., Davenport K.L., Davenport P.W. Perception of intrinsic and extrinsic respiratory loads in children with life-threatening asthma. Pediatr Pulmonol 2002, 34:425-433.
18. Kikuchi Y., Okabe S., Tamura G., Hida W., Homma M., Shirato K., Takishima T. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. New Engl J Med 1994, 330:1329-1334.
19. Eckert D.J., Catcheside P.G., Smith J.H., Frith P.A., McEvoy R.D. Hypoxia suppresses symptom perception in asthma. Am J Resp Crit Care Med 2004, 169:1224-1230.
20. Holgate S.T., Yang Y., Haitchi H.M., Powell R.M., Holloway J.W., Yoshisue H., Pang Y.Y., Cakebread J., Davies D.E. The genetics of asthma: ADAM33 as an example of a susceptibility gene. Proc Am Thorac Soc 2006, 3:440-443.
21. Israel E., Drazen J.M., Liggett S.B., Boushey H.A., Cherniack R.M., Chinchilli V.M., Cooper D.M., et al. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. The effect of polymorphisms of the beta2-adrenergic receptor on the response to regular use of albuterol in asthma. Int Arch Allergy Immunol 2001, 124:183-186.
22. Glassroth J. The role of long-acting beta agonists in the management of asthma: Analysis, meta-analysis, and more analysis. Ann Int Med 2006, 144:936-937.
23. Wechsler M.E., Kunselman S.J., Chinchilli V.M., Bleecker E., Boushey H.A., Calhoun W.J., Ameredes B.T., et al. Effect of beta2-adrenergic receptor polymorphism on response to long acting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet 2009, 374:1754-1764.
24. Benfield G.F., O'Doherty K., Davies B.H. Status asthmaticus and the syndrome of inappropriate secretion of antidiuretic hormone. Thorax 1982, 37:147-148.
25. Aikawa T., Shimura S., Sasaki H., Ebina M., Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992, 101:916-921.
26. Rubin B.K., Tomkiewicz R., Fahy J.V., Green F.H. Histopathology of fatal asthma: drowning in mucus. Pediatr Pulmonol 2001, (Suppl 23):88-89.
27. Sheehan J.K., Richardson P.S., Fung D.C., Howard M., Thornton D.J. Analysis of respiratory mucus glycoproteins in asthma: a detailed study from a patient who died in status asthmaticus. Am J Respir Cell Mol Biol 1995, 13:748-756.
28. Kurashima K., Fujimura M., Matsuda T., Kobayashi T. Surface activity of sputum from acute asthmatic patients. Am J Respir Critical Care Med 1997, 155:1254-1259.
29. Bowton D.L., Seeds M.C., Fasano M.B., Goldsmith B., Bass D.A. Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am J Resp Crit Care Med 1997, 155:421-425.
30. Fahy J.V., Kim K.W., Liu J., Boushey H.A. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbations. J Allerg Clin Immunol 1995, 95:843-852.
31. Lamblin C., Gosset P., Tillie-Leblond I., Saulnier F., Marquette C.H., Wallaert B., Tonnel A.B. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 1998, 157:394-402.
32. Ordonez C.L., Shaughnessy T.E., Matthay M.A., et al. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance. Am J Respir Crit Care Med 2000, 161:1185-1190.
33. Fahy J.V. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc Am Thorac Soc 2009, 6:256-259.
34. Zhang X., Moilanen E., Kankaanranta H. Beclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosis. Eur J Pharmacol 2001, 431:365-371.
35. Rollins D.R., Beuther D.A., Martin R.J. Update on infection and antibiotics in asthma. Curr Allergy Asthma Rep 2010, 10:67-73.
36. Kanoh S., Rubin B.K. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 2010, 23:590-615.
37. Chu H.W., Halliday J.L., Martin R.J., Leung D.Y.M., Szefler S.J., Wenzel S.E. Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med 1998, 158:1936-1944.
38. Moore W.C., Bleecker E.R., Curran-Everett D., Erzurum S.C., Ameredes B.T., Bacharier L., Calhoun W.J., et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. JAllergy Clin Immunol 2007, 119:405-413.
39. Miranda C., Busacker A., Balazar S., Trudeau J., Wenzel S.E. Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004, 113:101-108.
40. Rodrigo G.J., Rodriquez Verde M., Peregalli V., Rodrigo C. Effects of short-term 28% and 100% oxygen on PaCO2 and peak expiratory flow rate in acute asthma: a randomized trial. Chest 2003, 124:1312-1411.
41. Chien J.W., Ciufo R., Novak R., Skowronski M., Nelson J., Coreno A., McFadden E.R. Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest 2000, 117:728-733.
42. Travers A.H., Rowe B.H., Barker S., Jones A., Camargo C.A. The effectiveness of IV beta-agonists in treating patients with acute asthma in the emergency department: a meta-analysis. Chest 2002, 122:1200-1207.
43. Bogie A.L., Towne D., Luckett P.M., Abramo T.J., Wiebe R.A. Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus. Pediatr Emerg Care 2007, 23:355-361.
44. Tobin A. Intravenous salbutamol: too much of a good thing?. Crit Care Resusc 2005, 7:119-127.
45. Raimondi A.C., Schottlender J., Lombardi D., Molfino N.A. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder. Chest 1997, 112:24-28.
46. Rodrigo G.J., Rodrigo C. Continuous vs intermittent beta-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis. Chest 2002, 122:160-225.
47. Spitzer W.O., Suissa S., Ernst P., Horwitz R.I., Habbick B., Cockcroft D., Boivin J.F., McNutt M., Buist A.S., Rebuck A.S. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992, 326:501-506.
48. Tal A., Pasterkamp H., Leahy F. Arterial oxygen desaturation following salbutamol inhalation in acute asthma. Chest 1984, 86:868-869.
49. Andrews T., McGintee E., Mittal M.K., Tyler L., Chew A., Zhang X., Pawlowski N., Zorc J.J. High-dose continuous nebulized levalbuterol for pediatric status asthmaticus: a randomized trial. J Pediatr 2009, 155:205-210.
50. Rodrigo G.J., Castro-Rodriguez J.A. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005, 60:740-746.
51. Plotnick L.H., Ducharme F.M. Acute asthma in children and adolescents: should inhaled anticholinergics be added to beta2-agonists?. Am J Respir Med 2003, 2:109-115.
52. Mitra A., Bassler D., Goodman K., Lasserson T.J., Ducharme F.M. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Database Syst Rev 2005, CD001276.
53. Tough S.C., Green F.H., Paul J.E., Wigle D.T., Butt J.C. Sudden death from asthma in 108 children and young adults. J Asthma 1996, 33:179-188.
54. Rowe B.H., Bota G.W., Fabris L., Therrien S.A., Milner R.A., Jacono J. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA 1999, 281:2119-2126.
55. Rowe B.H., Camargo C.A. The role of magnesium sulfate in the acute and chronic management of asthma. Curr Opin Pulm Med 2008, 14:70-76.
56. Morris C.R., Becker A.B., Piñieiro A., Massaad R., Green S.A., Smugar S.S., Gurner D.M. A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma. Ann Allergy Asthma Immunol 2010, 104:161-171.
57. Camargo C.A., Gurner D.M., Smithline H.A., et al. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol 2010, 125:374-380.
58. Voynow J.A., Rubin B.K. Mucus, mucins, and sputum. Chest 2009, 135:505-512.
59. Stather D.R., Stewart T.E. Clinical review: Mechanical ventilation in severe asthma. Crit Care 2005, 9:581-587.
60. Oddo M., Feihl F., Schaller M.D., Perret C. Management of mechanical ventilation in acute severe asthma: practical aspects. Intensive Care Med 2006, 32:501-510.
61. Rodrigo G., Pollack C., Rodrigo C., Rowe B.H. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2006, CD00288.
62. Rubin B.K. What does it mean when a patient says, " My asthma medication is not working?" . Chest 2004, 126:972-981.
63. Birkhead G., Attaway N.J., Strunk R.C., Townsend M.C., Teutsch S. Investigation of a cluster of deaths of adolescents from asthma: evidence implicating inadequate treatment and poor patient adherence with medications. J Allergy Clin Immunol 1989, 84:484-491.
64. Wenzel S.E., Busse W.W. the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Severe asthma: lessons from the Severe Asthma Research Program. J Allergy Clin Immunol 2007, 119:14-21.